MetLife Investment Management’s Amplitude AMPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$359K Buy
52,663
+1,322
+3% +$10.9K ﹤0.01% 1914
2025
Q4
$595K Sell
51,341
-1,361
-3% -$14.3K ﹤0.01% 1712
2025
Q3
$565K Hold
52,702
﹤0.01% 1748
2025
Q2
$654K Buy
52,702
+5,642
+12% +$61K ﹤0.01% 1554
2025
Q1
$480K Sell
47,060
-443
-0.9% -$5.23K ﹤0.01% 1751
2024
Q4
$501K Buy
47,503
+4,839
+11% +$48.4K ﹤0.01% 1794
2024
Q3
$383K Hold
42,664
﹤0.01% 1929
2024
Q2
$380K Buy
42,664
+6,397
+18% +$60.1K ﹤0.01% 1874
2024
Q1
$395K Hold
36,267
﹤0.01% 1806
2023
Q4
$461K Hold
36,267
﹤0.01% 1740
2023
Q3
$420K Hold
36,267
﹤0.01% 1736
2023
Q2
$399K Buy
36,267
+6,111
+20% +$65.9K ﹤0.01% 1850
2023
Q1
$375K Hold
30,156
﹤0.01% 1822
2022
Q4
$364K Hold
30,156
﹤0.01% 1840
2022
Q3
$467K Hold
30,156
﹤0.01% 1692
2022
Q2
$431K Buy
+30,156
New +$529K ﹤0.01% 1770

Other funds holding AMPL

MetLife Investment Management's AMPL Position: Q1 2026 in Review

MetLife Investment Management increased its Amplitude (AMPL) stake by 2.6% in Q1 2026, buying an estimated $10.9K and bringing the position to 52,663 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

MetLife Investment Management first reported a position in AMPL in Q2 2022 and has held it in 16 quarters since. The position peaked at $654K in Q2 2025. 218 funds tracked by Wall St. Rank hold AMPL as of Q1 2026.

  • MetLife Investment Management held 52,663 shares of Amplitude worth $359K as of Q1 2026.
  • MetLife Investment Management bought 1,322 Amplitude shares in Q1 2026, an estimated $10.9K.
  • Amplitude made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1914 holding.
  • MetLife Investment Management first reported a position in Amplitude in Q2 2022 and has held it in 16 quarters since.
  • MetLife Investment Management's Amplitude position peaked at $654K in Q2 2025.
  • 218 funds tracked by Wall St. Rank held Amplitude as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.